Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 1, 2022
Patent Application Number
16779517
Date Filed
January 31, 2020
Patent Citations
Patent Primary Examiner
Patent abstract
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated modulate the NMDA receptor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
